12-11030872-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_176885.2(TAS2R31):c.464C>A(p.Thr155Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000234 in 1,613,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_176885.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R31 | NM_176885.2 | c.464C>A | p.Thr155Lys | missense_variant | 1/1 | ENST00000390675.2 | NP_795366.2 | |
PRH1-TAS2R14 | NM_001316893.2 | c.140+3910C>A | intron_variant | NP_001303822.1 | ||||
PRH1-PRR4 | NR_037918.2 | n.477+3910C>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R31 | ENST00000390675.2 | c.464C>A | p.Thr155Lys | missense_variant | 1/1 | NM_176885.2 | ENSP00000375093 | P1 | ||
ENST00000703543.1 | c.-126+16148C>A | intron_variant | ENSP00000515364 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152178Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.0000999 AC: 25AN: 250172Hom.: 0 AF XY: 0.0000958 AC XY: 13AN XY: 135668
GnomAD4 exome AF: 0.000254 AC: 371AN: 1461814Hom.: 0 Cov.: 120 AF XY: 0.000238 AC XY: 173AN XY: 727200
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152178Hom.: 0 Cov.: 35 AF XY: 0.0000673 AC XY: 5AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2022 | The c.464C>A (p.T155K) alteration is located in exon 1 (coding exon 1) of the TAS2R31 gene. This alteration results from a C to A substitution at nucleotide position 464, causing the threonine (T) at amino acid position 155 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at